Andera Partners Long-Term Concentrated

Location: Paris, France

CIK: 0001757283 · Show all filings

Period: Q2 2026 (← Previous) (Next →)

Filing Date: Jul 22, 2026

Total Value: $206M (100.0% shares, 0.0% debt)

Holdings (8)

KMTS KESTRA MED TECHNOLOGIES LTD 33.6%
Value $69.42M Shares 2,728,679 Share Price $25.44 Est. Cost/Share $25.57 Unrealized @ Report Date -0.5%
MLYS MINERALYS THERAPEUTICS INC 20.8%
Value $42.95M Shares 1,591,917 Share Price $26.98 Est. Cost/Share $40.10 Unrealized @ Report Date -32.7%
AVLN AVALYN PHARMACEUTICALS INC 14.8%
Value $30.61M Shares 929,824 Share Price $32.92 Est. Cost/Share $28.86 Unrealized @ Report Date +14.1%
AGMB AGOMAB THERAPEUTICS NV 9.7%
Value $19.97M Shares 1,538,702 Share Price $12.98 Est. Cost/Share $14.16 Unrealized @ Report Date -8.4%
EVMN EVOMMUNE INC 9.0%
Value $18.5M Shares 1,391,990 Share Price $13.29 Est. Cost/Share $18.78 Unrealized @ Report Date -29.2%
IVA INVENTIVA SA 6.7%
Value $13.73M Shares 3,633,181 Share Price $3.78 Est. Cost/Share $4.73 Unrealized @ Report Date -20.0%
ABVX ABIVAX SA 5.0%
Value $10.41M Shares 78,125 Share Price $133.26 Est. Cost/Share $109.11 Unrealized @ Report Date +22.1%
NYXH NYXOAH S A 0.4%
Value $882K Shares 522,057 Share Price $1.69 Est. Cost/Share $4.22 Unrealized @ Report Date -60.0%